| ||
| ||
| Oncolytic Virus Therapy Firms Merge Genetic Engineering News DNAtrix and VectorLogics have merged into a single entity that will retain the DNAtrix name and continue to develop the latter's lead early clinical-stage oncolytic virus-based glioblastoma therapy, DNX-2401. DNAtrix is focused on the development of ... See all stories on this topic » | ||
|
This as-it-happens Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment